Biotechnology Licensing Agreement Trends Analysis Report 2025 | Navigate the Licensing Landscape - Top Deals and Active Dealmaker Insights - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Licensing Deals in Biotechnology 2019-2025" has been added to ResearchAndMarkets.com's offering.

This report contains a comprehensive listing of licensing deals announced since 2019 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual licensing contract documents as submitted to the Securities Exchange Commission by companies and their partners.

The report provides access to licensing deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered and rights transferred - contract documents provide this insight where press releases and databases do not.

The initial chapters of this report establish an understanding of licensing dealmaking. Chapter 1 introduces the report, while Chapter 2 delves into licensing trends and the merits of various deal types. Chapter 3 outlines the structure of licensing deals. Chapter 4 reviews significant deals since 2019, and Chapter 5 lists the top 25 most active dealmakers. Chapter 6 categorizes deals by company, therapy, technology, and industry since 2019, providing detailed contract insights.

Licensing Deals in Biotechnology provides the reader with the following key benefits:

• Understand deal trends since 2019
• Browse licensing deals
• Benchmark analysis - identify market value of transactions
• Financials terms - upfront, milestone, royalties
• Directory of deals by company A-Z, therapy focus and technology type
• Leading deals by value
• Most active dealmakers
• Identify assets and deal terms for each transaction
• Access contract documents - insights into deal structures
• Due diligence - assess suitability of your proposed deal terms for partner companies
• Save hundreds of hours of research time

Key Topics Covered:

Chapter 1 - Introduction

Chapter 2 - Trends in licensing dealmaking

2.1. Introduction

2.2. Definition of licensing deal

2.3. Trends in licensing deals since 2019

2.3.1. Licensing dealmaking by year, 2019-2025

2.3.2. Licensing dealmaking by phase of development, 2019-2025

2.3.3. Licensing dealmaking by industry sector, 2019-2025

2.3.4. Licensing dealmaking by therapy area, 2019-2025

2.3.5. Licensing dealmaking by technology type, 2019-2025

2.3.6. Licensing dealmaking by most active company, 2019-2025

2.4. Reasons for entering into licensing partnering deals

2.5. The future of licensing deals

Chapter 3 - Overview of licensing deal structure

3.1. Introduction

3.2. Licensing agreement structure

Chapter 4 - Leading licensing deals

4.1. Introduction

4.2. Top licensing deals by value

Chapter 5 - Top 25 most active licensing dealmakers

5.1. Introduction

5.2. Top 25 most active licensing dealmakers

Chapter 6 - Licensing deals including contracts directory

6.1. Introduction

6.2. Licensing deals with contracts 2019-2025

Deal directory

• Deal directory - licensing dealmaking by companies A-Z
• Deal directory - licensing dealmaking by therapy area
• Deal directory - licensing dealmaking by technology type

Companies Featured (Partial)

• Abbott Laboratories
• Pfizer
• Moderna
• Johnson & Johnson
• Amgen
• Roche
• Sanofi
• Merck and Co
• Novartis
• GlaxoSmithKline
• AstraZeneca
• Gilead Sciences
• Bristol-Myers Squibb
• BioNTech
• Regeneron Pharmaceuticals
• Lilly
• Takeda Pharmaceutical
• Biogen
• CSL Behring
• Elanco
• Illumina
• Vertex Pharmaceuticals
• Seagen
• Alnylam Pharmaceuticals
• Moderna Therapeutics
• CRISPR Therapeutics
• MindBio Therapeutics
• BioArctic AB
• Regeneron
• Genentech
• Veeva Systems
• CureVac
• Medtronic
• Stryker
• Thermo Fisher Scientific
• Boehringer Ingelheim
• Bayer
• Zoetis
• Idorsia
• AbbVie
• Bausch Health Companies
• Mundipharma
• Reckitt Benckiser
• Philips
• Siemens
• Daichi Sankyo
• Sun Pharmaceutical
• Sandoz
• Hikma Pharmaceuticals
• Teva Pharmaceuticals USA

For more information about this report visit https://www.researchandmarkets.com/r/hc7pu5

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.